The former Vaccination Calendar of the Canary Islands is now renamed the Immunization Calendar for all ages, reflecting the incorporation of new preparations such as the monoclonal antibody against the Respiratory Syncytial Virus (RSV). This update, published in the Official Gazette of the Canary Islands (BOC) on July 14, is based on epidemiological data, international trends, and recent scientific evidence.
The main novelty is the introduction of RSV vaccination. Starting this autumn, it will be administered to adults over 70 years residing in socio-sanitary centers and to those under that age with severe chronic respiratory or cardiac diseases. It will also be offered to non-institutionalized individuals with hematological cancers or transplant recipients, through specialized hospital services.
The new calendar also includes other significant changes: a booster of the Tdpa vaccine against pertussis for fourteen-year-old adolescents; the administration of a single dose against the Human Papillomavirus (HPV) for unvaccinated individuals aged thirteen to twenty years and for high-risk groups; the adoption of a twenty-valent conjugate preparation for the Pneumococcus vaccine; and the offer of the vaccine against Meningococcus (serotypes A, C, W, Y) to individuals under nineteen years with incomplete or unreceived vaccination schedules.
Furthermore, vaccination against Hepatitis A is introduced for individuals under nineteen years traveling to endemic areas and for adults in prostitution and men who have sex with men (MSM) without age limit. Vaccination against Hepatitis B is reinforced in adults with risk factors, and protection against Herpes Zóster is extended to individuals at higher risk of complications.
Finally, a specific vaccination program for healthcare students will be launched during 2026, funded by the General Directorate of Public Health. Vaccination with two doses of the MMR vaccine against measles is also recommended for individuals born in Spain from 1978 onwards who have not had the disease or cannot certify two correctly administered doses.
